The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impact of pre-cancer (Ca) diagnosis (Dx) psychiatric utilization (PU) on survival in patients with solid organ ca: A population analysis in Ontario, Canada.
 
Zachary William Abraham Klaassen
Honoraria - BioSyent
Research Funding - Astellas Oncology; BioSyent
 
Christopher J.D. Wallis
No Relationships to Disclose
 
Hanan Goldberg
No Relationships to Disclose
 
Thenappan Chandrasekar
No Relationships to Disclose
 
Rashid K. Sayyid
No Relationships to Disclose
 
Neil Eric Fleshner
Honoraria - Janssen Oncology
Consulting or Advisory Role - Abbvie; Janssen Oncology; Sanofi
Speakers' Bureau - Abbvie; Janssen Oncology; Sanofi
Research Funding - Abbvie; Janssen Oncology
 
Antonio Finelli
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb; Roche Pharma AG
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Roche Canada; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Roche Canada; Sanofi
 
Robert Nam
No Relationships to Disclose
 
Stephen Bentley Williams
No Relationships to Disclose
 
Paul Kurdyak
No Relationships to Disclose
 
Girish S. Kulkarni
Honoraria - Abbvie; AstraZeneca; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; BioSyent; Ferring; Janssen
Research Funding - Astellas Pharma; BioSyent